已收录 268921 条政策
 政策提纲
  • 暂无提纲
Effect of the 5-Hydroxytryptamine3 (5-HT3)-Receptor Antagonist KB-R6933 on Experimental Diarrhea Models
[摘要] References(15)Cited-By(3)The effects of a 5-hydroxytryptamine3 (5-HT3)-receptor antagonist KB-R6933 (6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)-benzimidazole dimaleate) on experimental diarrhea and on intestinal fluid secretion stimulated by cholera toxin were examined and compared with those of ramosetron and loperamide. KB-R6933 and ramosetron (0.03 - 1 mg/kg, p.o.) inhibited the diarrhea induced by 5-HT, but not that by castor oil or prostaglandin E2 (PGE2), in mice. Loperamide significantly inhibited the diarrhea induced by 5-HT, castor oil and PGE2. All drugs tested inhibited the diarrhea induced by restraint stress and the intestinal fluid secretion stimulated by cholera toxin in rats. The results suggest the possibility that KB-R6933 may have clinical efficacy in the treatment of diarrhea.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词] KB-R6933;5-HT3 receptor antagonist;Diarrhea [时效性] 
   浏览次数:6      统一登录查看全文      激活码登录查看全文